These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23819873)

  • 21. Validation of the urinary sensation scale (USS).
    Coyne KS; Margolis MK; Hsieh R; Vats V; Chapple CR
    Neurourol Urodyn; 2011 Mar; 30(3):360-5. PubMed ID: 21254195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder.
    Coyne KS; Matza LS; Kopp Z; Abrams P
    Eur Urol; 2006 Jun; 49(6):1079-86. PubMed ID: 16460875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms.
    Brubaker L; Piault EC; Tully SE; Evans CJ; Bavendam T; Beach J; Yeh Y; Kopp ZS; Khullar V; Kelleher CJ; Trocio J
    Int J Clin Pract; 2013 Apr; 67(4):342-50. PubMed ID: 23521326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinence.
    Patrick DL; Khalaf KM; Dmochowski R; Kowalski JW; Globe DR
    Clin Ther; 2013 Jun; 35(6):836-45. PubMed ID: 23747076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Responsiveness and minimal clinically important change in overactive bladder symptom score.
    Gotoh M; Homma Y; Yokoyama O; Nishizawa O
    Urology; 2011 Oct; 78(4):768-73. PubMed ID: 21855969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM; Carrico DJ; Wooldridge LS; Miller CJ; MacDiarmid SA
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adaptation and validation in the French language of the International Score of Symptoms of Benign Prostatic Hypertrophy].
    Sagnier PP; Richard F; Botto H; Teillac P; Dreyfus JP; Boyle P
    Prog Urol; 1994; 4(4):532-8; discussion 539-40. PubMed ID: 7522745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder.
    Harpe SE; Szeinbach SL; Caswell RJ; Corey R; McAuley JW
    J Urol; 2007 Dec; 178(6):2532-6; discussion 2536. PubMed ID: 17937937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IQOL: translation & reliability for use with urinary incontinence patients in Thailand.
    Chaisaeng S; Santingamkun A; Opanuraks J; Ratchanon S; Bunyaratavej C
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S33-9. PubMed ID: 17722303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
    Ito H; Sano F; Ogawa T; Yao M
    Int J Urol; 2014 Jan; 21(1):108-12. PubMed ID: 23662900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U; Viterbo W; Bittencourt J; Farias T; LordĂȘlo P
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder.
    Liu HT; Kuo HC
    J Urol; 2008 Jun; 179(6):2270-4. PubMed ID: 18423678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between the self-perception period of overactive bladder symptoms and overactive bladder symptom scores in a non-treated population and related sociodemographic and lifestyle factors.
    Kim JH; Ham BK; Shim SR; Lee WJ; Kim HJ; Kwon SS; Bae JH
    Int J Clin Pract; 2013 Aug; 67(8):795-800. PubMed ID: 23869680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of overactive bladder symptom on quality of life in stroke patients.
    Itoh Y; Yamada S; Konoeda F; Koizumi K; Nagata H; Oya M; Suzuki N
    Neurourol Urodyn; 2013 Jun; 32(5):428-34. PubMed ID: 23129306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of variability in urinary incontinence and overactive bladder symptoms.
    Stewart WF; Minassian VA; Hirsch AG; Kolodner K; Fitzgerald M; Burgio K; Cundiff GW; Blaivas J; Newman D; Lerch VR; Dilley A
    Neurourol Urodyn; 2010 Mar; 29(3):328-35. PubMed ID: 19693956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overactive bladder and underactive bladder: a symptom syndrome or urodynamic diagnosis?
    Chapple C
    Neurourol Urodyn; 2013 Apr; 32(4):305-7. PubMed ID: 23592009
    [No Abstract]   [Full Text] [Related]  

  • 38. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).
    Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS
    Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Debilitating lower urinary tract symptoms in the post-renal transplant population can be predicted pretransplantation.
    Dion M; Cristea O; Langford S; Luke PP; Sener A
    Transplantation; 2013 Feb; 95(4):589-94. PubMed ID: 23263609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overactive bladder syndrome - management and treatment options.
    Arnold J; McLeod N; Thani-Gasalam R; Rashid P
    Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.